Publications of Hannelore Ehrenreich
All genres
Journal Article (245)
21.
Journal Article
92 (4), pp. P254 - 255 (2022)
Quo Vaditis Anti-Brain Autoantibodies: Causes, Consequences, or Epiphenomena? Biological Psychiatry 22.
Journal Article
27, pp. 4974 - 4983 (2021)
NMDAR1 autoantibodies amplify behavioral phenotypes of genetic white matter inflammation: a mild encephalitis model with neuropsychiatric relevance. Molecular Psychiatry 23.
Journal Article
90 (9), pp. 611 - 620 (2021)
A comparison of ten polygenic score methods for psychiatric disorders applied across multiple cohorts. Biological Psychiatry 24.
Journal Article
96, pp. 73 - 79 (2021)
Autoantibodies against the NMDAR subunit NR1 are associated with neuropsychiatric outcome after ischemic stroke. Brain, Behavior, and Immunity 25.
Journal Article
26, pp. 7746 - 7759 (2021)
Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis. Molecular Psychiatry 26.
Journal Article
9, 121 (2021)
Inducing sterile pyramidal neuronal death in mice to model distinct aspects of gray matter encephalitis. Acta Neuropathologica Communications 27.
Journal Article
26 (7), pp. 3211 - 3222 (2021)
Preadult polytoxicomania—strong environmental underpinnings and first genetic hints. Molecular Psychiatry 28.
Journal Article
7 (2), veab058 (2021)
Human genomics of the humoral immune response against polyomaviruses. Virus Evolution 29.
Journal Article
26 (6), pp. 1723 - 1725 (2021)
Spontaneous serum autoantibody fluctuations: To be or not to be. Molecular Psychiatry 30.
Journal Article
26 (6), pp. 2471 - 2482 (2021)
Multiple inducers and novel roles of autoantibodies against the obligatory NMDAR subunit NR1: a translational study from chronic life stress to brain injury. Molecular Psychiatry 31.
Journal Article
22 (6), 3164 (2021)
CaMKIIα Expressing Neurons to Report Activity-Related Endogenous Hypoxia upon Motor-Cognitive Challenge. International Journal of Molecular Sciences 32.
Journal Article
27, 120 (2021)
Addressing the ‘hypoxia paradox’ in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues. Molecular Medicine 33.
Journal Article
26, pp. 1790 - 1807 (2021)
Hippocampal neurons respond to brain activity with functional hypoxia. Molecular Psychiatry 34.
Journal Article
118 (50), pp. A2394 - A2396, A3 (2021)
Erythropoietin: Hypoxia paradox in COVID-19. Deutsches Ärzteblatt 35.
Journal Article
36, 109548 (2021)
Brain erythropoietin fine-tunes a counterbalance between neurodifferentiation and microglia in the adult hippocampus. Cell Reports 36.
Journal Article
582, pp. 577 - 581 (2020)
Complement genes contribute sex-biased vulnerability in diverse disorders. Nature 37.
Journal Article
26, 58 (2020)
Erythropoietin as candidate for supportive treatment of severe COVID-19. Molecular Medicine 38.
Journal Article
22, 100345 (2020)
Accumulated environmental risk in young refugees – A prospective evaluation. EClinicalMedicine 39.
Journal Article
11, 1313 (2020)
Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin. Nature Communications 40.
Journal Article
2, pp. 18 - 32 (2020)
Vascular response to social cognitive performance measured by infrared thermography: A translational study from mouse to man. FASEB BioAdvances